Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,411 public trials 1,032 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

NCT04797767

Conditions: Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +26 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma

NCT07224100

Conditions: B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Lymphoblastic Leukemia/Lymphoma With t(9;22)(q34.1;q11.2); BCR-ABL1, Hematologic Diseases, +11 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

MB-dNPM1-TCR.1 in Relapsed/Refractory AML

NCT06424340

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations: Leiden University Medical Center Leiden, Netherlands

View Trial Details

Recruiting

Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

NCT00816114

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy

NCT06439199

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations: Nantes University Hospital Nantes, Loire-Atlantique, France

View Trial Details

Recruiting

Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm

NCT04140487

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases

NCT07493538

Conditions: AML, Acute Leukemia, Acute Myeloid Leukemia, +10 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS

NCT07532824

Conditions: Acute Myeloid Leukemia (AML), Anemia, Anemia, Refractory, +14 more
Locations: Institute of Hematology and Blood Transfusion Prague, Czechia

Proton Therapy Center Czech Prague, Czechia

View Trial Details

Recruiting

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

NCT03418038

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +27 more
Locations: Mayo Clinic Health Systems-Mankato Mankato, Minnesota, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

Mayo Clinic Health System-Eau Claire Clinic Eau Claire, Wisconsin, United States

Mayo Clinic Health System-Franciscan Healthcare La Crosse, Wisconsin, United States

View Trial Details

Recruiting

The Efficacy of Allo-HSCT in ND HR-CBF-AML

NCT06458244

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiaotong University School Of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Leukemia

Leukemia trial results

Related conditions